Mesa Laboratories Inc

XNASInformation technology

Last traded price · USD

$126.21

+0.02%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 14:59 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $126.19
Volume: 223
Day's high: —
Day's low: —

In brief

Mesa Laboratories Inc is an information technology company listed on Nasdaq, valued at about $706M.
Its shares closed at $126.19 on 4 Nov 2026, up 71.1% over the past year.
From India you can buy MLAB in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Mesa Laboratories Inc (MLAB) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole MLAB share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade MLAB options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Ahead of SPY and its sector fund XLK over 1 year
1 month: −7.3% (SPY −1.6%, XLK −12.6%). 3 months: +23.0% (SPY −0.4%, XLK −5.1%). 1 year: +71.1% (SPY +13.6%, XLK +20.1%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: MLAB, SPY and XLK · as of 4 Nov 2026
Below its 50-day average, above its 200-day
The 4 Nov 2026 close of $126.19 was 1.8% below its 50-day average ($128.46) and 20.5% above its 200-day average ($104.75). It has closed above the 200-day for 162 sessions, since 17 Mar 2026. The 50-day average crossed above the 200-day on 13 Feb 2026, 182 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Next ex-dividend date: 30 Nov 2026
$0.16 a share, payable 15 Dec 2026; unchanged from the previous payment (ex-date 31 Aug 2026).
Corporate actions record · as of 5 Nov 2026
76% of the way up its 52-week range
Closed at $126.19 on 4 Nov 2026: 12.6% below the 52-week high of $144.35 (6 Oct 2026) and 81.5% above the low of $69.51 (18 Nov 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026
Short interest at 7.0% of shares outstanding
390.6K shares were sold short at the 15 Oct 2026 settlement, 7.0% of the 5.6M shares outstanding; covering them would take 3.8 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−7.3%

6 months+19.1%

1 year+71.1%

5 years−59.6%

Newswire

About

Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Website

Notable moves

March 10, 2026
−16.49%
August 5, 2025
−24.92%
November 3, 2022
+15.27%

Newswire

About

Website

Notable moves

March 10, 2026
−16.49%
August 5, 2025
−24.92%
November 3, 2022
+15.27%

Mesa Laboratories Inc

XNASInformation technology

Last traded price · USD

$126.21

+0.02%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 14:59 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $126.19
Volume: 223
Day's high: —
Day's low: —

In brief

Mesa Laboratories Inc is an information technology company listed on Nasdaq, valued at about $706M.
Its shares closed at $126.19 on 4 Nov 2026, up 71.1% over the past year.
From India you can buy MLAB in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Mesa Laboratories Inc (MLAB) shares from India?

Do I need the price of a whole MLAB share to invest?

How much can I invest in US stocks in a year?

Can I trade MLAB options or futures?

Insights

Quotes run fifteen minutes behind.

Ahead of SPY and its sector fund XLK over 1 year
1 month: −7.3% (SPY −1.6%, XLK −12.6%). 3 months: +23.0% (SPY −0.4%, XLK −5.1%). 1 year: +71.1% (SPY +13.6%, XLK +20.1%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: MLAB, SPY and XLK · as of 4 Nov 2026
Below its 50-day average, above its 200-day
The 4 Nov 2026 close of $126.19 was 1.8% below its 50-day average ($128.46) and 20.5% above its 200-day average ($104.75). It has closed above the 200-day for 162 sessions, since 17 Mar 2026. The 50-day average crossed above the 200-day on 13 Feb 2026, 182 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Next ex-dividend date: 30 Nov 2026
$0.16 a share, payable 15 Dec 2026; unchanged from the previous payment (ex-date 31 Aug 2026).
Corporate actions record · as of 5 Nov 2026
76% of the way up its 52-week range
Closed at $126.19 on 4 Nov 2026: 12.6% below the 52-week high of $144.35 (6 Oct 2026) and 81.5% above the low of $69.51 (18 Nov 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026
Short interest at 7.0% of shares outstanding
390.6K shares were sold short at the 15 Oct 2026 settlement, 7.0% of the 5.6M shares outstanding; covering them would take 3.8 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−7.3%

6 months+19.1%

1 year+71.1%

5 years−59.6%

Newswire

About

Website

Notable moves

March 10, 2026
−16.49%
August 5, 2025
−24.92%
November 3, 2022
+15.27%

Newswire

About

Website

Notable moves

March 10, 2026
−16.49%
August 5, 2025
−24.92%
November 3, 2022
+15.27%

Mesa Laboratories Inc

Mesa Laboratories Inc in brief

Ahead of SPY and its sector fund XLK over 1 year

Below its 50-day average, above its 200-day

Next ex-dividend date: 30 Nov 2026

76% of the way up its 52-week range

Short interest at 7.0% of shares outstanding

Mesa Laboratories Inc

Mesa Laboratories Inc in brief

Ahead of SPY and its sector fund XLK over 1 year

Below its 50-day average, above its 200-day

Next ex-dividend date: 30 Nov 2026

76% of the way up its 52-week range

Short interest at 7.0% of shares outstanding